| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |